Shares of life science companies rose Wednesday after Swiss drugmaker Roche made a hostile offer to buy Illumina Inc. for $5.7 billion.Illumina makes systems that analyze an individual’s DNA, and Roche …

Go here to read the rest:
Sector Wrap: Life science stocks jump on Roche bid